Cresco Labs Inc. (OTCMKTS:CRLBF – Free Report) – Equities researchers at Cormark cut their FY2024 earnings per share (EPS) estimates for shares of Cresco Labs in a report issued on Monday, November 11th. Cormark analyst J. Pytlak now expects that the company will earn ($0.21) per share for the year, down from their prior forecast of ($0.17). Cormark currently has a “Hold” rating on the stock. The consensus estimate for Cresco Labs’ current full-year earnings is ($0.20) per share. Cormark also issued estimates for Cresco Labs’ FY2025 earnings at $0.03 EPS.
CRLBF has been the subject of a number of other reports. Needham & Company LLC reiterated a “hold” rating on shares of Cresco Labs in a report on Monday, August 12th. Roth Capital upgraded Cresco Labs to a “strong-buy” rating in a research note on Sunday, November 10th. Finally, Ventum Cap Mkts upgraded Cresco Labs to a “strong-buy” rating in a research note on Friday, August 9th. Three equities research analysts have rated the stock with a hold rating, two have issued a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $2.50.
Cresco Labs Price Performance
Shares of OTCMKTS CRLBF opened at $1.39 on Thursday. Cresco Labs has a twelve month low of $1.02 and a twelve month high of $2.65. The company has a current ratio of 1.97, a quick ratio of 1.30 and a debt-to-equity ratio of 1.80. The company has a market capitalization of $678.51 million, a price-to-earnings ratio of -7.00 and a beta of 1.88. The business has a 50 day simple moving average of $1.57 and a 200-day simple moving average of $1.70.
Cresco Labs Company Profile
Cresco Labs Inc, together with its subsidiaries, cultivates, manufactures, and sells retail and medical cannabis products in the United States. It provides cannabis in flowers, vape pens, live resins, disposable pens, and extracts under the Cresco brand; vape carts, vape pens, flower, popcorn, shake, pre-rolls, shorties, and concentrates under the High Supply brand; vapes and gummies under the Good News brand; vapes and edibles under the Wonder Wellness Co brand; and tinctures, capsules, salves, and sublingual oils under the Remedi brand.
Read More
- Five stocks we like better than Cresco Labs
- Most Volatile Stocks, What Investors Need to Know
- How Whitestone REIT Is Transforming Sun Belt Retail Growth
- Stock Average Calculator
- Top-Performing Non-Leveraged ETFs This Year
- Are Penny Stocks a Good Fit for Your Portfolio?
- Rivian’s Wild Ride: Is the Dip a Buying Opportunity?
Receive News & Ratings for Cresco Labs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cresco Labs and related companies with MarketBeat.com's FREE daily email newsletter.